北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 819-823. doi: 10.3969/j.issn.1671-167X.2017.05.013

• 论著 • 上一篇    下一篇

类风湿关节炎患者髓系来源的抑制细胞促进自身B细胞增殖

陈玮1, 2, 胡凡磊1, 刘洪江1, 徐丽玲1, 李英妮1, 栗占国1   

  1. 1. 北京大学人民医院风湿免疫科,风湿病机制及免疫诊断北京市重点实验室,北京 100044;
    2.成都医学院免疫学教研室,成都 610500
  • 收稿日期:2015-12-23 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家自然科学基金(81671604、81302554、81401341)资助

Myeloid-derived suppressor cells promoted autologous B cell proliferation in rheumatoid arthritis

CHEN Wei1, 2, HU Fan-lei1, LIU Hong-jiang1, XU Li-ling1, LI Ying-ni1, LI Zhan-guo1   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital &
    Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing 100044, China;
    2.Department of Immunology, Chengdu Medical College, Chengdu 610500, China
  • Received:2015-12-23 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Natural Science Foundation of China (81671604, 81302554,81401341)

摘要: 目的 探讨类风湿关节炎(rheumatoid arthritis,RA)患者髓系来源的抑制细胞(myeloid-derived suppressor cells,MDSC)对自身B细胞增殖的影响,揭示MDSC在RA发病中的作用。方法 健康对照15例,RA患者38例,按28-关节疾病活动度分值(28-joint disease activity score,DAS28)分为高疾病活动度组(DAS28>5.1)、中疾病活动度组(3.2<DAS28≤5.1)和低疾病活动度组(2.6<DAS28≤3.2), 流式细胞术检测其外周血MDSC细胞的比例;同时分选10例高疾病活动度RA患者外周血B细胞和MDSC细胞体外共培养,羟基荧光素二醋酸盐琥珀酰亚胺酯(carboxyfluorescein diacetate succinimidyl ester,CFSE)法检测B细胞的增殖。结果 高疾病活动度RA外周血MDSC比例(7.13%±2.17%)相对于健康成年人(4.79%±1.02%)、中活动度患者(5.35%±1.36%)和低活动度患者(4.72%±1.08%)明显增加(P<0.05),而中、低疾病活动度RA之间及其二者与健康成年人之间差异皆无统计学意义(P>0.05);MDSC比例与患者DAS28分值成正相关(P<0.05),与年龄、病程、类风湿因子(rheumatoid factor,RF)、抗环瓜氨酸多肽(cyclic citrullinated peptide,CCP)抗体等无相关性;MDSC共培养不抑制反而促进B细胞的增殖(P<0.01)。结论 MDSC在高疾病活动度RA患者外周血中明显增加,与疾病活动度呈正相关,并可在体外促进自身B细胞的增殖,提示MDSC可能通过调节B细胞的功能参与RA的疾病进程。

关键词: 髓系来源的抑制细胞, 关节炎, 类风湿, B淋巴细胞, 细胞增殖

Abstract: Objective: To investigate the effect of myeloid-derived suppressor cells (MDSC) on pro-liferation of B lymphocytes in rheumatoid arthritis (RA) patients. Methods: The peripheral blood specimens were collected from 15 healthy adults and 38 RA patients who were divided into high disease activity group, medium activity group and low activity group according to their 28-joint disease activity score (DAS28). And the frequencies of MDSC were determined by flow cytometry. Then, B cells and MDSC were isolated by flow cytometry, respectively. B cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) and then were co-cultured with MDSC in the presence of 3 mg/L anti-CD40 antibody and 10 mg/L CpG, for 3 days. Flow cytometry was performed to investigate the proliferation of B cells. Results: MDSC expanded markedly in high disease activity patients (7.13%±2.17%) compared with medium (5.35%±1.36%) and low disease activity patients (4.72%±1.08%) or healthy controls (4.79%±1.02%) (P<0.05), and there were no statistical differences between healthy controls, medium and low disease activity RA (P>0.05). Moreover, the frequencies of MDSC were positively correlated with the DAS28 (P<0.05). After co-culture, MDSC significantly promoted B cell proliferation (P<0.01). Conclusion: Our studies showed that MDSC expanded obviously in high disease activity RA patients, and their frequencies were positively correlated with the disease activities. Furthermore, MDSC could promote autologous B cell proliferation remarkably in vitro. These findings suggest that MDSC might be involved in RA pathogenesis through regulating B cell functions.

Key words: Myeloid-derived suppressor cells, Arthritis, rheumatoid, B-lymphocytes, Cell proliferation

中图分类号: 

  • R593.22
[1] Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis [J]. Cell, 1996, 85(3): 307-310.
[2] Bax M, Huizinga TW, Toes RE. The pathogenic potential of autoreactive antibodies in rheumatoid arthritis [J]. Semin Immunopathol, 2014, 36(3): 313-325.
[3] Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system [J]. Nat Rev Immunol, 2009, 9(3): 162-174.
[4] Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells [J]. Immunol Rev, 2008(222): 162-179.
[5] Crook KR, Liu P. Role of myeloid-derived suppressor cells in autoimmune disease [J]. World J Immunol, 2014, 4(1): 26-33.
[6] Guo C, Hu F, Yi H, et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis [J]. Ann Rheum Dis, 2016, 75(1): 278-285.
[7] Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J]. N Engl J Med, 2004, 350(25): 2572-2581.
[8] Young MR, Newby M, Wepsic TH. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors [J]. Cancer Res, 1987, 47(1): 100-106.
[9] 许为民, 龚爱华, 王慧, 等. 类风湿关节炎患者外周血髓系来源的抑制细胞的检测及与Th1/Th2细胞的相关性分析[J]. 江苏大学学报(医学版), 2013, 23(2): 140-143.
[10] Li Y, Tu Z, Qian S, et al. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis [J]. J Immunol, 2014, 193(5): 2127-2134.
[11] Crook KR, Jin M,Weeks MF, et al. Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease [J]. J Leukoc Biol, 2015, 97(3): 573-582.
[1] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[2] 李正芳,罗采南,武丽君,吴雪,孟新艳,陈晓梅,石亚妹,钟岩. 抗氨基甲酰化蛋白抗体在诊断类风湿关节炎中的应用价值[J]. 北京大学学报(医学版), 2024, 56(4): 729-734.
[3] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[4] 张瑶,郭金鑫,战世佳,洪恩宇,杨慧,贾安娜,常艳,郭永丽,张璇. 富含半胱氨酸和甘氨酸蛋白2在神经母细胞瘤恶性进展中的功能和机制[J]. 北京大学学报(医学版), 2024, 56(3): 495-504.
[5] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[6] 李红光,韩玮华,吴训,冯继玲,李刚,孟娟红. 关节腔冲洗联合液态浓缩生长因子注射治疗单侧颞下颌关节骨关节炎的初步研究[J]. 北京大学学报(医学版), 2024, 56(2): 338-344.
[7] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[8] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
[9] 张警丰,金银姬,魏慧,姚中强,赵金霞. 体重指数与类风湿关节炎临床特征的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 993-999.
[10] 金银姬,孙琳,赵金霞,刘湘源. 血清IgA型抗鼠科肉瘤病毒癌基因同源物B1抗体在类风湿关节炎中的意义[J]. 北京大学学报(医学版), 2023, 55(4): 631-635.
[11] 蔡文心,李仕成,刘一鸣,梁如玉,李静,郭建萍,胡凡磊,孙晓麟,李春,刘栩,叶华,邓立宗,李茹,栗占国. 类风湿关节炎临床分层及其特征的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1068-1073.
[12] 程昉,杨邵英,房星星,王璇,赵福涛. CCL28-CCR10通路在类风湿关节炎单核细胞迁移中的作用[J]. 北京大学学报(医学版), 2022, 54(6): 1074-1078.
[13] 刘蕊,赵金霞,闫良. 类风湿关节炎合并下肢静脉血栓患者的临床特点[J]. 北京大学学报(医学版), 2022, 54(6): 1079-1085.
[14] 张警丰,金银姬,魏慧,姚中强,赵金霞. 类风湿关节炎患者生活质量与疾病活动度的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1086-1093.
[15] 徐朝焰,林长艺,叶达梅,吴培埕,宋明辉,刘有添,邓琼,黄雪艳,范忠晓,游雪兰. 感染性关节炎诊断分析[J]. 北京大学学报(医学版), 2022, 54(6): 1234-1237.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!